Action 2877 CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués China Shineway Pharmaceutical Group Limited

Actions

2877

KYG2110P1000

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:09:05 07/06/2024 		Varia. 5j. Varia. 1 janv.
8,23 HKD -1,20 % Graphique intraday de China Shineway Pharmaceutical Group Limited -1,56 % +13,20 %
28/03 China Shineway Pharmaceutical Group Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
08/03 China Shineway Pharmaceutical enregistrera un bénéfice plus élevé en 2023 ; les actions augmentent de 3%. MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
China Shineway Pharmaceutical : Shineway (2877.HK) Q1 revenue increased by 37.0%
AQ
China Shineway Pharmaceutical : TURNOVER FOR THE FIRST QUARTER OF 2021
PU
China Shineway Pharmaceutical : Form of proxy for use at the annual general meeting to be held on Friday, 28 May 2021 (or at any adjournment thereof)
PU
China Shineway Pharmaceutical : Proposals for General Mandates to Repurchase Shares and to issue shares, Re-election of Retiring Directors, Declaration of Final Dividend and Notice of Annual General Meeting
PU
China Shineway Pharmaceutical : records 29.4% revenue growth in October
AQ
China Shineway Pharmaceutical : Interim Report 2020
PU
China Shineway Pharmaceutical : CONNECTED TRANSACTION TECHNICAL SERVICES AGREEMENT
PU
China Shineway Pharmaceutical : TURNOVER FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
PU
China Shineway Pharmaceutical : Announcements and Notices - List of Directors and Their Roles and Functions
PU
China Shineway Pharmaceutical : Announcements and Notices - Cessation of Executive Director and Chief Executive Officer
PU
China Shineway Pharmaceutical : Announcements and Notices - Turnover for the First Quarter of 2019
PU
China Shineway Pharmaceutical : Change of Name of Principal Share Registrar and Transfer Office in the Cayman Islands
PU
China Shineway Pharmaceutical : Resignation of Independent Non-executive Director, Member of Audit Committee and Member of Nomination Committee
PU
China Shineway Pharmaceutical : Announces Annual Results - Turnover Reached RMB1,993 million, Proposed Final and Special Dividend Totaling RMB21 Cents per Share
PU
China Shineway Pharmaceutical : Announcement of Turnover Information for the Nine Months Ended 30 September 2016
PU
China Shineway Pharmaceutical : Announces Interim Results for the Six Months Ended 30 June 2016 - Turnover Amounted to RMB931.6 Million, Proposed Interim Dividend of RMB11 Cents per Share
PU
China Shineway Pharmaceutical : Profit Warning
PU
China Shineway Pharmaceutical : Connected Transaction Disposal of the Entire Equity Interests in Jing Li Yuan Biotechnology Limited
PU
China Shineway Pharmaceutical : Announcements and Notices - Grant of Options under the Share Option Scheme
PU
China Shineway Pharmaceutical : Announcements and Notices - Announcement of Turnover Information for the Three Months Ended 31 March 2016
PU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2877
  4. Actualités China Shineway Pharmaceutical Group Limited
  5. Communiqués